Bank Of New York Mellon Corp Vertex Pharmaceuticals Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $595 Million - $669 Million	2,082,299 New	2,082,299 $601 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $4.61 Million - $5.14 Million	-16,831 Reduced 0.8%	2,081,470 $603 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $22.4 Million - $27.9 Million	95,436 Added 4.76%	2,098,301 $591 Million
Q1 2022 May 11, 2022	SELL	$221.42 - $260.97 $13.3 Million - $15.6 Million	-59,941 Reduced 2.91%	2,002,865 $523 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $4.6 Million - $5.81 Million	-25,982 Reduced 1.24%	2,062,806 $453 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $4.7 Million - $5.26 Million	-25,930 Reduced 1.23%	2,088,788 $379 Million
Q2 2021 Aug 11, 2021	SELL	$187.49 - $221.1 $6.36 Million - $7.51 Million	-33,948 Reduced 1.58%	2,114,718 $426 Million
Q1 2021 May 13, 2021	SELL	$207.02 - $241.31 $27.6 Million - $32.1 Million	-133,222 Reduced 5.84%	2,148,666 $462 Million
Q4 2020 Feb 09, 2021	SELL	$207.01 - $276.09 $65.3 Million - $87.1 Million	-315,296 Reduced 12.14%	2,281,888 $539 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $22.2 Million - $26.4 Million	87,014 Added 3.47%	2,597,184 $707 Million
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $3.96 Million - $5.19 Million	17,545 Added 0.7%	2,510,170 $729 Million
Q1 2020 May 06, 2020	SELL	$199.77 - $247.81 $3.35 Million - $4.16 Million	-16,775 Reduced 0.67%	2,492,625 $593 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $12 Million - $16.2 Million	-72,194 Reduced 2.8%	2,509,400 $549 Million
Q3 2019 Nov 07, 2019	BUY	$166.23 - $187.09 $572,496 - $644,337	3,444 Added 0.13%	2,581,594 $437 Million
Q2 2019 Aug 12, 2019	BUY	$164.61 - $190.37 $48.7 Million - $56.4 Million	296,068 Added 12.97%	2,578,150 $473 Million
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $12.6 Million - $15 Million	76,930 Added 3.49%	2,282,082 $420 Million
Q4 2018 Feb 11, 2019	SELL	$151.91 - $192.21 $19 Million - $24 Million	-124,886 Reduced 5.36%	2,205,152 $365 Million
Q3 2018 Nov 09, 2018	SELL	$167.73 - $192.74 $93,425 - $107,356	-557 Reduced 0.02%	2,330,038 $0
Q2 2018 Aug 06, 2018	SELL	$145.72 - $169.96 $3.13 Million - $3.65 Million	-21,447 Reduced 0.91%	2,330,595 $396 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $50.4 Million - $58.9 Million	332,476 Added 16.46%	2,352,042 $383 Million
Q4 2017 Feb 09, 2018	BUY	$137.28 - $155.55 $277 Million - $314 Million	2,019,566	2,019,566 $303 Million

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.1 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.4 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.61 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.33 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.06 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account